[1] GREENBAUM L A, BENNDORF R, SMOYER W E. Childhood nephrotic syndrome-current and future therapics[J]. Nat Rev Nephrol, 2012,8(8):445-458. [2] TIKELLIS C, BERNARDI S, BURNS W C. Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease[J]. Curr Opin Nephrol Hypertens, 2011, 20(1): 62-68. [3] PRASUN P, PRASAD N, TRIPATHI G, et al. Association of angiotensin-converting enzyme gene I/D polymorphism with steroid responsiveness in childhood nephrotic syndrome[J]. Indian J Nephrol, 2011, 21(1): 26-29. [4] MIZUIRI S, OHASHI Y.ACE and ACE2 in kidney disease[J]. World J Nephrol, 2015,4(1): 74-82. [5] QIU M Y, XIE Q F, WANG L N, et al.Association between angiotensin-converting enzyme 2 gene polymorphisms and childhood primary nephrotic syndrome[J]. Zhongguo Dang Dai Er Ke Za Zhi, 2015,17 (3): 232-236. [6] PATEL V B, ZHONG J C, GRANT M B, et al. Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure[J]. Circ Res, 2016,118(8):1313-1326. [7] SHIOTA A, YAMAMOTO K, OHISHI M, et al. Loss of ACE2 accelerates time-dependent glomerular and tubul ointerstitial damage in streptozotocin-induced diabetic mice[J]. Hypertens Res, 2010, 33(4): 298-307. [8] OUDIT G Y, LIU G C, ZHONG J, et al. Human recombinant ACE2 reduces the progression of diabetic nephropathy[J]. Diabetes,2010, 59(2):529-538. [9] Eräranta A, RIUTTA A, FAN M, et al. Dietary phosphate binding and loading alter kidney angiotensin-converting enzyme mRNA and protein content in 5/6 nephrectomized rats[J]. Am J Nephrol, 2012, 35(5): 401-408. [10] CHAOXIN J, DAILI S, YANXIN H, et al. The influence of angiotensin-converting enzyme 2 gene polymorphisms on type 2 diabetes mellitus and coronary heart disease[J]. Eur Rev Med Pharmacol, 2013, 17(19): 2654-2659. [11] SOLER M J, WYSOCKI J, BATLLE D. ACE2 alterations in kidney disease[J]. Nephrol Dial Transplant,2013,28(11):2687-2697. [12] REICH H N, OUDIT G Y, PENNINGER J M, et al. Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease[J]. Kidney Int, 2008,74(12):1610-1616. [13] BATLLE D, WYSOCKI J, SOLER M J, et al. Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy[J]. Kidney Int, 2012,81(6):520-528. [14] LIU B C, GAO J, LI Q, et al. Albumin caused the increasing production of angiotensin II due to the dysregulation of ACE/ACE2 expression in HK2 cells[J]. Clin Chim Acta, 2009, 403(1-2): 23-30. [15] YE M, WYSOCKI J, WILLIAM J, et al. Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes[J]. J Am Soc Nephrol,2006,17(11):3067-3075. |